The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Linco-Ject 300This page contains information on Linco-Ject 300 for veterinary use.
The information provided typically includes the following:
- Linco-Ject 300 Indications
- Warnings and cautions for Linco-Ject 300
- Direction and dosage information for Linco-Ject 300
Linco-Ject 300This treatment applies to the following species:
INJECTION 300 mg/mL
STERILE LINCOMYCIN HYDROCHLORIDE INJECTION
brand of Lincomycin hydrochloride injectable
For Intramuscular Use in Swine Only
LINCO-JECT Injectable contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis, which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.
Linco-Ject 300 Indications For Swine
LINCO-JECT Injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as the staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of mycoplasma pneumonia.
As with all drugs, the use of LINCO-JECT Injectable is contraindicated in animals previously found to be hypersensitive to the drug.
Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment. Not for human use.
Linco-Ject 300 Caution
If no improvement is noted within 48 hours, consult a veterinarian.
The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.
Linco-Ject 300 Dosage And Administration
For arthritis or mycoplasma pneumonia-5mg per pound of body weight intramuscularly once daily for three to seven days as needed. When using LINCO-JECT Injectable containing 300 mg/mL, 1 mL/60 lb. body weight will provide 5 mg/lb.
For optimal results, initiate treatment as soon as possible. As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.
LINCO-JECT Injectable is available in one concentration: 300 mg/mL.
300 mg/mL: For use in swine weighing 300 pounds or more. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 300 mg; also Benzyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.
Store at controlled room temperature: 20° to 25°C (68° to 77°F) [see USP].
ANADA#: 200-315, Approved by F.D.A.
Mfd. in U.S.A.
Manufactured for Agripharm Products, Westlake, TX 76262 U.S.A.
Manufactured by Veterinary Laboratories, Inc., Lenexa, KS 66215, USA
Distributed by: Dealer Distribution of America
NAC No.: 14571531
822 7TH STREET, SUITE 605, GREELEY, CO, 80631
|Every effort has been made to ensure the accuracy of the Linco-Ject 300 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-09-29